Sphingosine kinase signalling in immune cells: Potential as novel therapeutic targets

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1784, Issue 1, 2008, Pages 66-75

  Melendez, Alirio J ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Immune cell; Inflammation; Lymphocytes; Mast cell; Monocytes macrophage; Neutrophil; Signalling; Sphingosine kinase; Sphingosine 1 phosphate

Indexed keywords

ACYLSPHINGOSINE DEACYLASE; ANTIGEN; CERAMIDE; CYTOKINE; G PROTEIN COUPLED RECEPTOR; GROWTH FACTOR; SPHINGOLIPID; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE KINASE;

APOPTOSIS; CALCIUM MOBILIZATION; CELL ACTIVATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CHEMOTAXIS; CYTOKINE PRODUCTION; CYTOSKELETON; DEGRANULATION; DNA SYNTHESIS; EXTRACELLULAR MATRIX; GENE; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOSTIMULATION; INFLAMMATION; INHIBITION KINETICS; LIPID METABOLISM; LYMPHOCYTE; MACROPHAGE; MAST CELL; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION; STRESS FIBER;

ANIMALS; AUTOIMMUNE DISEASES; CALCIUM SIGNALING; CELL ADHESION MOLECULES; CERAMIDES; HUMANS; HYPERSENSITIVITY; IMMUNE SYSTEM; INFLAMMATION; LYMPHOCYTES; LYSOPHOSPHOLIPIDS; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); SIGNAL TRANSDUCTION; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOMYELINS; SPHINGOSINE;

EID: 38149117052     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbapap.2007.07.013     Document Type: Review

References (107)

1. Merrill Jr. A.H., Schmelz E.M., Dillehay D.L., Spiegel S., Shayman J.A., Schroeder J.J., Riley R.T., Voss K.A., and Wang E. Sphingolipids - the enigmatic lipid class: biochemistry, physiology, and pathophysiology. Toxicol. Appl. Pharmacol. 142 (1997) 208-225
2. Hannun Y.A. The sphingomyelin cycle and the second messenger functions of Ceramide. J. Biol. Chem. 269 (1994) 3125-3128
3. Kee T.H., Vit P., and Melendez A.J. Sphingosine kinase signalling in immune cells. Clin. Exp. Pharmcol. Physiol. 32 (2005) 153-161
4. Baumruker T., and Prieschl E.E. Sphingolipids and the regulation of the immune response. Semin. Immunol. 14 (2002) 57-63
5. Spiegel S. Sphingosine 1-phospate: a prototype of a new class of second messengers. J. Leuoc. Biol. 65 (1999) 341-344
6. Spiegel S., and Milstien S. Sphingosine 1-phosphate, a key cell signaling molecule. J. Biol. Chem. 277 (2002) 25851-25854
7. Van Brocklyn J.R., Lee M.J., Menzeleev R., Olivera A., Edsall L., Cuvillier O., Thomas D.M., Coopman P.J., Thangada S., Liu C.H., Hla T., and Spiegel S. Dual actions of sphingosine-1-phosphate: extracellular through the Gi-coupled receptor Edg-1 and intracellular to regulate proliferation and survival. J. Cell Biol. 142 (1998) 229-240
8. Pyne S., and Pyne N.J. Sphingosine 1-phosphate signalling in mammalian cells. Biochem. J. 349 (2000) 385-402
9. Ott V.L., and Cambier J.C. Introduction: multifaceted roles of lipids and their catabolites in immune cell signalling. Semin. Immunol. 14 (2002) 1-6
10. Rosen H., and Goetzl E.J. Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network. Nat. Rev., Immunol. 5 (2005) 560
11. Ozaki H., Hla T., and Lee M.J. Sphingosine-1-phosphate signaling in endothelial activation. J. Atheroscler. Thromb. 10 (2003) 125-131
12. Kohama T., Olivera A., Edsall L., Nagiec M.M., Dickson R., and Spiegel S. Molecular cloning and functional characterization of murine sphingosine kinase. J. Biol. Chem. 273 (1998) 23722-23728
13. Melendez A.J., Carlos-Dias E., Gosink M., Allen J.M., and Takacs L. Human sphingosine kinase: molecular cloning, functional characterization and tissue distribution. Gene 251 (2000) 19-26
14. Pitson S.M., D'Andrea R.J., Vandeleur L., Moretti P.A., Xia P., Gamble J.R., Vadas M.A., and Wattenberg B.W. Human sphingosine kinase: purification, molecular cloning and characterization of the native and recombinant enzymes. Biochem. J. 350 (2000) 429-441
15. Liu H., Sugiura M., Nava V.E., Edsall L.C., Kono K., Poulton S., Milstien S., Kohama T., and Spiegel S. Molecular cloning and functional characterization of a novel mammalian sphingosine kinase type 2 isoform. J. Biol. Chem. 275 (2000) 19513-19520
16. Buehrer B.M., and Bell R.M. Sphingosine kinase: properties and cellular functions. Adv. Lipid Res. 26 (1993) 59-67
17. Edsall L.C., Van Brocklyn J.R., Cuvillier O., Kleuser B., and Spiegel S. N,N-dimethylsphingosine is a potent competitive inhibitor of sphingosine kinase but not of protein kinase C: modulation of cellular levels of sphingosine 1-phosphate and Ceramide. Biochemistry 15 (1998) 301-304
18. Alemany R., Meyer zu Heringdorf D., Koppen C.J., and Jakobs K.H. Formyl peptide receptor signaling in HL-60 cells through sphingosine kinase. J. Biol. Chem. 274 (1999) 3994-3999
19. 2+ signals triggered by different phospholipid pathways in antigen stimulation of human mast cells. J. Biol. Chem. 277 (2002) 17255-17262
20. Choi O.H., Kim J.H., and Kinet J.P. Calcium mobilization via sphingosine kinase in signaling by the FcεRI antigen receptor. Nature 380 (1996) 634-636
21. Melendez A.J., Floto R.A., Gillooly D.J., Harnett M.M., and Allen J.M. FcγRI coupling to phospholipase D initiates sphingosine kinase mediated calcium mobilization and vesicular trafficking. J. Biol. Chem. 273 (1998) 9393-9402
22. English D., Welch Z., Kovala A.T., Harvey K., Volpert O.V., Brindley D.N., and Garcia J.G. Sphingosine 1-phosphate released from platelets during clotting accounts for the potent endothelial cell chemotactic activity of blood serum and provides a novel link between hemostasis and angiogenesis. FASEB J. 14 (2000) 2255-2265
23. Shu X., Wu W., Mosteller R.D., and Broek D. Sphingosine kinase mediates vascular endothelial growth factor-induced activation of ras and mitogen-activated protein kinases. Mol. Cell. Biol. 22 (2002) 7758-7768
24. Cuvillier O. Sphingosine in apoptosis signaling. Biochim. Biophys. Acta 1585 (2002) 153-162
25. Maceyka M., Payne S.G., Milstien S., and Spiegel S. Sphingosine kinase, sphingosine-1-phospate, and apoptosis. Biochim. Biophys. Acta 1585 (2002) 193-201
26. Olivera A., Kohama T., Edsall L., Nava V., Cuvillier O., Poulton S., and Spiegel S. Sphingosine kinase expression increase intracellular sphingosine-1-phosphate and promotes cell growth and survival. J. Cell Biol. 147 (1999) 545-558
27. Edsall L.C., Cuvillier O., Twitty S., Spiegel S., and Milstien S. Sphingosine kinase expression regulates apoptosis and caspase activation in PC12 cells. J. Neurochem. 76 (2001) 1573-1584
28. 2+ signals enzyme release, cytokine production, and chemotaxis. J. Immunol. 173 (2004) 1596-1603
29. Ibrahim F.B.M., Pang S.-J., and Melendez A.J. Anaphylatoxin signaling in human neutrophils: a key role for sphingosine kinase. J. Biol. Chem. 279 (2004) 44802-44811
30. Jayapal M., Tay H.K., Reghunathan R., Zhi L., Chow K.K., Rauff M., and Melendez A.J. Genome-wide gene expression profiling of human mast cells stimulated by IgE or FcepsilonRI-aggregation reveals a complex network of genes involved in inflammatory responses. BMC Genomics 7 (2006) 210
31. Van Brocklyn J.R., Lee M.J., Menzeleev R., Olivera A., Edsall L., Cuvillier O., Thomas D.M., Coopman P.J., Thangada S., Liu C.H., Hla T., and Spiegel S. Dual actions of sphingosine-1-phosphate: extracellular through the Gi-coupled receptor Edg-1 and intracellular to regulate proliferation and survival. J. Cell. Biol. 142 (1998) 229-240
32. Hla T., Lee M.J., Ancellin N., Paik J.H., and Kluk M.J. Lysophospholipids - receptor revelations. Science 294 (2001) 1875-1878
33. Goetzl E.J., and An S. Diversity of cellular receptors and functions for the lysophospholipid growth factors lysophosphatidic acid and sphingosine 1-phosphate. FASEB J. 12 (1998) 1589-1598
34. An S., Goetzl E.J., and Lee H. Signaling mechanisms and molecular characteristics of G protein-coupled receptors for lysophosphatidic acid and sphingosine 1-phosphate. J. Cell Biochem. Suppl. 30-31 (1998) 147-157
35. Beaven M.A. Calcium signaling: sphingosine kinase versus phospholipase C. Curr. Biol. 6 (1996) 798-801
36. Melendez A.J., Floto R.A., Gillooly D.J., Harnett M.M., and Allen J.M. FcγRI coupling to phospholipase D initiates sphingosine kinase mediated calcium mobilization and vesicular trafficking. J. Biol. Chem. 273 (1998) 9393-9402
37. Olivera A., Edsall L., Poulton S., Kazlauskas A., and Spiegel S. Platelet-derived growth factor-induced activation of sphingosine kinase requires phosphorylation of the PDGF receptor tyrosine residue responsible for binding of PLCgamma. FASEB J. 13 (1999) 1593-1600
38. Bornfeldt K.E., Graves L.M., Raines E.W., Igarashi Y., Wayman G., Yamamura S., Yatomi Y., Sidhu J.S., Krebs E.G., Hakomori S., and Ross R. Sphingosine-1-phosphate inhibits PDGF-induced chemotaxis of human arterial smooth muscle cells: spatial and temporal modulation of PDGF chemotactic signal transduction. J. Cell Biol. 130 (1995) 193-206
39. English D., Welch Z., Kovala A.T., Harvey K., Volpert O.V., Brindley D.N., and Garcia J.G. Sphingosine 1-phosphate released from platelets during clotting accounts for the potent endothelial cell chemotactic activity of blood serum and provides a novel link between hemostasis and angiogenesis. FASEB J. 14 (2000) 2255-2265
40. Kimura T., Sato K., Kuwabara A., Tomura H., Ishiwara M., Kobayashi I., Ui M., and Okajima F. Sphingosine 1-phosphate may be a major component of plasma lipoproteins responsible for the cytoprotective actions in human umbilical vein endothelial cells. J. Biol. Chem. 276 (2001) 31780-31785
41. Kon J., Sato K., Watanabe T., Tomura H., Kuwabara A., Kimura T., Tamama K., Ishizuka T., Murata N., Kanda T., Kobayashi I., Ohta H., Ui M., and Okajima F. Comparison of intrinsic activities of the putative sphingosine 1-phosphate receptor subtypes to regulate several signaling pathways in their cDNA-transfected Chinese hamster ovary cells. J. Biol. Chem. 274 (1999) 23940-23947
42. Van Brocklyn J.R., Behbahani B., and Lee N.H. Homodimerization and heterodimerization of S1P/EDG sphingosine-1-phosphate receptors. Biochim. Biophys. Acta. 1582 (2002) 89-93
43. Lee M.J., Van Brocklyn J.R., Thangada S., Liu C.H., Hand A.R., Menzeleev R., Spiegel S., and Hla T. Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1. Science 279 (1998) 1552-1555
44. Zhang Q., Peyruchaud O., French K.J., Magnusson M.K., and Mosher D.F. Sphingosine 1-phosphate stimulates fibronectin matrix assembly through a Rho-dependent signal pathway. Blood 93 (1999) 2984-2990
45. Lee M.J., Thangada S., Claffey K.P., Ancellin N., Liu C.H., Kluk M., Volpi M., Sha'afi R.I., and Hla T. Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate. Cell 99 (1999) 301-312
46. Cuvillier O., Pirianov G., Kleuser B., Vanek P.G., Coso O.A., Gutkind S., and Spiegel S. Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature 381 (1996) 800-803
47. Labesse G., Dougert D., Assairi L., and Gilles A.M. Diacylglyceride kinases, sphingosine kinases and NAD kinases: distant relatives of 6-phosphofructokinases. Trends Biochem. Sci. 27 (2002) 273-275
48. Liu H., Chakravarty D., Maceyka M., Milstien S., and Spiegel S. Sphingosine kinases: a novel family of lipid kinases. Prog. Nucleic Acid Res. 71 (2002) 493-511
49. Liu H., Sugiura M., Nava V.E., Edsall L.C., Kono K., Poulton S., Milstien S., Kohama T., and Spiegel S. Molecular cloning and functional characterization of a novel mammalian sphingosine kinase type 2 isoform. J. Biol. Chem. 275 (2000) 19513-19520
50. Lanterman M.M., and Saba J.D. Characterization of sphingosine kinase (SK) activity in Saccharomyces cerevisiae and isolation of SK-deficient mutants. Biochem. J. 332 (1998) 525-531
51. Nagiec M.M., Skrzypek M., Nagiec E.E., Lester R.L., and Dickson R.C. The LCB4 (YOR171c) and LCB5 (YLR260w) genes of Saccharomyces encode sphingoid long chain base kinases. J. Biol. Chem. 273 (1998) 19437-19442
52. Wang S., Banno Y., and Nozawa Y. Two forms of membrane-bound sphingosine kinase in Tetrahymena and activity changes during growth and the cell cycle. J. Eukaryot. Microbiol. 49 (2002) 305-311
53. Nishiura H., Tamura K., Morimoto Y., and Imai H. Characterization of sphingolipid long-chain base kinase in Arabidopsis thaliana. Biochem. Soc. Trans. 28 (2000) 747-748
54. Gijsbers S., Van der Hoeven G., and Van Veldhoven P.P. Subcellular study of sphingoid base phosphorylation in rat tissues: evidence for multiple sphingosine kinases. Biochim. Biophys. Acta. 1532 (2001) 37-50
55. Alemany R., van Koppen C.J., Danneberg K., ter Braak M., and Meyer zu Henringdorf D. Regulation and functional roles of sphingosine kinases. Naunyn-Schmiedeberg's Arch. Pharmacol. 374 (2007) 413-428
56. Spiegel S., and Milstien S. Functions of the multifaceted family of sphingosine kinases and some close relatives. J. Biol. Chem. 282 (2007) 2125-2129
57. Berridge M.J., Lipp P., and Bootman M.D. The versatility and universality of calcium signalling. Nat. Rev., Mol. Cell Biol. 1 (2000) 11-21
58. Bootman M.D., Berridge M.J., and Roderick H.L. Calcium signalling: more messengers, more channels, more complexity. Curr. Biol. 12 (2002) R563-R565
59. 2+ signals. J. Cell Sci. 114 (2001) 2213-2222
60. 2+ in late endosome-lysosome heterotypic fusion and in the reformation of lysosomes from hybrid organelles. J. Cell Biol. 149 (2000) 1053-1062
61. Dayer J.M., and Burger D. Cell-cell interactions and tissue damage in rheumatoid arthritis. Autoimmun. Rev. 3 Suppl. 1 (2004) S14
62. McInnes I.B., Leung B.P., and Liew F.Y. Cell-cell interactions in synovitis: Interactions between T lymphocytes and synovial cells. Arthritis Res. 2 (2000) 374
63. Hohlfeld R., Meinl E., Weber F., Zipp F., Schmidt S., Sotgiu S., Goebels N., Voltz R., Spuler S., Iglesias A., et al. The role of autoimmune T lymphocytes in the pathogenesis of multiple sclerosis. Neurology 45 (1995) S33
64. Gracie J.A., Forsey R.J., Chan W.L., Gilmour A., Leung B.P., Greer M.R., Kennedy K., Carter R., Wei X.Q., Xu D., Field M., Foulis A., Liew F.Y., and McInnes I.B. A proinflammatory role for IL-18 in rheumatoid arthritis. J. Clin. Invest. 104 (1999) 1393
65. Vallejo A.N., Mugge L.O., Klimiuk P.A., Weyand C.M., and Goronzy J.J. Central role of thrombospondin-1 in the activation and clonal expansion of inflammatory T cells. J. Immunol. 164 (2000) 2947
66. Maceyka M., Payne S.G., Milstien S., and Spiegel S. Sphingosine kinase, sphingosine-1-phosphate, and apoptosis. Biochim. Biophys. Acta 1585 (2002) 193-201
67. Jolly P.S., Rosenfeldt H.M., Milstein S., and Spiegel S. The roles of sphingosine-1-phosphate in asthma. Mol. Immunol. 38 (2002) 1239-1245
68. Mori K., Itoi M., Tsukamoto N., Kubo H., and Amagai T. The perivascular space as a path of hematopoietic progenitor cells and mature T cells between the blood circulation and the thymic parenchyma. Int. Immunol. 19 (2007) 745-753
69. Brinkmann V., Pinschewer D.D., Feng L., and Chen S. FTY720: altered lymphocyte traffic results in allograft protection. Transplantation 72 (2001) 764-769
70. Yoshimoto T., Furuhata M., Kamiya S., Hisada M., Miyaji H., Magami Y., Yamamoto K., Fujiwara H., and Mizuguchi J. Positive modulation of IL-12 signaling by sphingosine kinase 2 associating with the IL-12 receptor beta 1 cytoplasmic region. J. Immunol. 171 (2003) 1352-1359
71. Olivera A., Kohama T., Edsall L., Nava V., Cuvillier O., Poulton S., and Spiegel S. Sphingosine kinase expression increase intracellular sphingosine-1-phosphate and promotes cell growth and survival. J. Cell Biol. 147 (1999) 545-558
72. Leung B.P., Culshaw S., Gracie J.A., Hunter D., Canetti C.A., Campbell C., Cunha F., Liew F.Y., and McInnes I.B. A role for IL-18 in neutrophil activation. J. Immunol. 167 (2001) 2879
73. Canetti C.A., Leung B.P., Culshaw S., McInnes I.B., Cunha F.Q., and Liew F.Y. IL-18 enhances collagen-induced arthritis by recruiting neutrophils via TNF-alpha and leukotriene B4. J. Immunol. 171 (2003) 1009
74. Zhang J.H., Ferrante A., Arrigo A.P., and Dayer J.M. Neutrophil stimulation and priming by direct contact with activated human T lymphocytes. J. Immunol. 148 (1992) 177
75. Zhang X., Kluger Y., Nakayama Y., Poddar R., Whitney C., DeTora A., Weissman S.M., and Newburger P.E. Gene expression in mature neutrophils: early responses to inflammatory stimuli. J. Leukoc. Biol. 75 (2004) 358
76. MacKinnon A.C., Buckley A., Chilvers E.R., Rossi A.G., Haslett C., and Sethi T. Sphingosine kinase: a point of convergence in the action of diverse neutrophil priming agents. J. Immunol. 169 (2002) 6394
77. Niwa M., Kozawa O., Matsuno H., Kanamori Y., Hara A., and Uematsu T. Tumor necrosis factor-alpha-mediated signal transduction in human neutrophils: involvement of sphingomyelin metabolites in the priming effect of TNF-alpha on the fMLP-stimulated superoxide production. Life Sci. 66 (2000) 245
78. Rosenfeld M.E., and Ross R. Macrophage and smooth muscle cell proliferation in atherosclerotic lesions of WHHL and comparably hypercholesterolemic fat-fed rabbits. Arteriosclerosis 10 (1990) 680
79. Sunderkotter C., Steinbrink K., Goebeler M., Bhardwaj R., and Sorg C. Macrophages and angiogenesis. J. Leukoc. Biol. 55 (1994) 410
80. English D., Garcia J.G., and Brindley D.N. Platelet-released phospholipids link haemostasis and angiogenesis. Cardiovasc. Res. 49 (2001) 588
81. Galli S.J., and Wershil B.K. The two faces of the mast cell. Nature 381 (1996) 21
82. Prieschl E.E., Csonga R., Novotny V., Kikuchi G.E., and Baumruker T. The balance between sphingosine and sphingosine-1-phosphate is decisive for mast cell activation after Fcε receptor I triggering. J. Exp. Med. 190 (1999) 1-8
83. Olivera A., Mizugishi K., Tikhonova A., Ciaccia L., Odom S., Proia R.L., and Rivera J. The sphingosine kinase-sphingosine-1-phosphate axis is a determinant of mast cell function and anaphylaxis. Immunity 26 (2007) 287
84. Yatomi Y., Igarashi Y., Yang L., Hisano N., Qi R., Asazuma N., Satoh K., Ozaki Y., and Kume S. Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum. J. Biochem. (Tokyo) 121 (1997) 969-973
85. Hla T., and Maciag T. An abundant transcript induced in differentiating human endothelial cells encodes a polypeptide with structural similarities to G-protein-coupled receptors. J. Biol. Chem. 265 (1990) 9308-9313
86. Ozaki H., Hla T., and Lee M.J. Sphingosine-1-phosphate signaling in endothelial activation. J. Atheroscler. Thromb. 10 (2003) 125-131
87. Rönnstrand L., and Heldin C.H. Mechanisms of platelet-derived growth factor-induced chemotaxis. Int. J. Cancer 91 (2001) 757-762
88. Ancellin N., Colmont C., Su J., Li Q., Mittereder N., Chae S.S., Stefansson S., Liau G., and Hla T. Extracellular export of sphingosine kinase-1 enzyme. Sphingosine 1-phosphate generation and the induction of angiogenic vascular maturation. J. Biol. Chem. 277 (2002) 6667-6675
89. Shu X., Wu W., Mosteller R.D., and Broek D. Sphingosine kinase mediates vascular endothelial growth factor-induced activation of ras and mitogen-activated protein kinases. Mol. Cell. Biol. 22 (2002) 7758-7768
90. Xia P., Gamble J.R., Rye K.A., Wang L., Hii C.S., Cockerill P., Khew-Goodaall Y., Bert A.G., Barter P.J., and Vadas M.A. Tumor necrosis factor-alpha induces adhesion molecule expression through the sphingosine kinase pathway. Proc. Natl. Acad. Sci. 95 (1998) 14196-14201
91. Zhi L., Leung B.P., and Melendez A.J. Sphingosine kinase 1 regulates pro-inflammatory responses triggered by TNF-α in primary human monocytes. J. Cell Physiol. 208 (2006) 109-115
92. Yanagawa Y., Sugahara K., Kataoka H., Kawaguchi T., Masubuchi Y., and Chiba K. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. II. FTY720 prolongs skin allograft survival by decreasing T cell infiltration into grafts but not cytokine production in vivo. J. Immunol. 160 (1998) 5493-5499
93. Yang Z., Chen M., Fialkow L.B., Ellett J.D., Wu R., Brinkmann V., Nadler J.L., and Lynch K.R. The immune modulator FYT720 prevents autoimmune diabetes in nonobese diabetic mice. Clin. Immunol. 107 (2003) 30-35
94. Matsuura M., Imayoshi T., and Okumoto T. Effect of FTY720, a novel immunosuppressant, on adjuvant- and collagen-induced arthritis in rats. Int. J. Immunopharmacol. 4 (2000) 323-331
95. Tedesco-Silva H., Mourad G., Kahan B.D., Boira J.G., Weimar W., Mulgaonkar S., Nashan B., Madsen S., Charpentier B., Pellet P., and Vanrenterghem Y. FTY720, a novel immunomodulator: efficacy and safety results from the first phase 2A study in de novo renal transplantation. Transplantation 79 (2005) 1553-1560
96. Kieseier B.C., Wiendl H., Hemmer B., and Hartung H.P. Treatment and treatment trials in multiple sclerosis. Curr. Opin. Neurol. 20 (2007) 286-293
97. Billich S., Bornancin F., Devay P., Mechtcheriakova D., Urtz N., and Baumruker T. Phosphorylation of the immunomodulatory drug FTY720 by sphingosine kinases. J. Biol. Chem. 278 (2003) 7408-47415
98. Paugh S.W., Payne S.G., Barbour S.E., Milstien S., and Spiegel S. The immunosuppressant FTY720 is phosphorylated by sphingosine kinase type 2. FEBS Lett. 554 (2003) 189-193
99. Allende M.L., Sasaki T., Kawai H., Olivera A., Mi Y., van Echten-Deckert G., Hajdu R., Rosenbach M., Keohane C.A., Mandala S., Spiegel S., and Proia R. Mice deficient in sphingosine kinase 1 are rendered lymphopenic by FTY720. J. Biol. Chem. 279 (2004) 52487-52492
100. Zemann B., Kinzel B., Muller M., Reuschel R., Mechtcheriakova D., Urtz N., Bornancin F., Baumruker T., and Billich A. Sphingosine kinase type 2 is essential for lymphopenia induced by the immunomodulatory drug FTY720. Blood 107 (2006) 1454-1458
101. Michaud J., Kohno M., Proia R.L., and Hla T. Normal acute and chronic inflammatory responses in sphingosine kinase 1 knockout mice. FEBS Lett. 580 (2006) 4607-4612
102. Cheng A.M., Negishi I., Anderson S.J., Chan A.C., Bolen J., Loh D.Y., and Pawson T. The Syk and ZAP-70 SH2-containing tyrosine kinases are implicated in pre-T cell receptor signaling. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 9797-9801
103. Williams C.S., Mann M., and DuBois R.N. The role of cyclooxygenases in inflammation, cancer, and development. Oncogene 18 (1999) 7908-7916
104. Liao J.J., Huang M.C., and Goetzl E.J. Cutting edge: alternative signaling of Th17 cell development by sphingosine 1-phosphate. J. Immunol. 178 (2007) 5425
105. Kuokkanen S., Gschwend M., Rioux J.D., Daly M.J., Terwilliger J.D., Tienari P.J., Wikstrom J., Palo J., Stein L.D., Hudson T.J., Lander E.S., and Peltonen E.A. Genomewide scan of multiple sclerosis in Finnish multiplex families. Am. J. Hum. Genet. 61 (1997) 1379-1387
106. Nair R.P., Henseler T., Jenisch S., Stuart P., Bichakjian C.K., Lenk W., Westphal E., Guo S.W., Christophers E., Voorhees J.J., and Elder J.T. Evidence for two psoriasis susceptibility loci (HLA and 17q) and two novel candidate regions (16q and 20p) by genome-wide scan. Hum. Mol. Genet. 8 (1977) 1349-1356
107. Enlund F., Samuelsson L., Enerback C., Inerot A., Wahlstrom J., Yhr M., Torinsson A., Martinsson T., and Swanbeck G. Analysis of three suggested psoriasis susceptibility loci in a large Swedish set of families: confirmation of linkage to chromosome 6p (HLA region) and to 17q, but not to 4q. Hum. Hered. 1 (1999) 2-8